Representative Josh Gottheimer (D-New Jersey) recently sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG). In a filing disclosed on October 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Intuitive Surgical stock on September 3rd. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.
Representative Josh Gottheimer also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Baldwin Insurance Group (NASDAQ:BWIN) on 9/23/2025.
- Purchased $1,001 – $15,000 in shares of CommVault Systems (NASDAQ:CVLT) on 9/23/2025.
- Purchased $1,001 – $15,000 in shares of Sysmex (OTCMKTS:SSMXY) on 9/22/2025.
- Purchased $1,001 – $15,000 in shares of Independence Realty Trust (NYSE:IRT) on 9/22/2025.
- Purchased $1,001 – $15,000 in shares of Natera (NASDAQ:NTRA) on 9/22/2025.
- Sold $1,001 – $15,000 in shares of Diageo (NYSE:DEO) on 9/22/2025.
- Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/22/2025.
- Sold $1,001 – $15,000 in shares of Trade Desk (NASDAQ:TTD) on 9/11/2025.
- Purchased $1,001 – $15,000 in shares of Natera (NASDAQ:NTRA) on 8/22/2025.
- Sold $1,001 – $15,000 in shares of Sysmex (OTCMKTS:SSMXY) on 8/21/2025.
Intuitive Surgical Stock Performance
Shares of ISRG stock opened at $446.13 on Friday. The company has a market capitalization of $159.93 billion, a PE ratio of 62.22, a price-to-earnings-growth ratio of 4.56 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business’s fifty day moving average is $454.97 and its 200 day moving average is $495.83.
Analysts Set New Price Targets
A number of brokerages recently weighed in on ISRG. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Mizuho lowered their price objective on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating on the stock in a research report on Tuesday. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company increased their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Finally, UBS Group set a $529.00 price target on Intuitive Surgical in a research report on Monday. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $580.29.
Check Out Our Latest Analysis on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In related news, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,224 shares of company stock worth $21,716,492. Insiders own 0.70% of the company’s stock.
Institutional Trading of Intuitive Surgical
Several hedge funds have recently added to or reduced their stakes in ISRG. Tobam grew its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in Intuitive Surgical during the 2nd quarter worth approximately $27,000. Chilton Capital Management LLC increased its stake in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. bought a new stake in Intuitive Surgical in the first quarter valued at approximately $26,000. Finally, Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors.
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Consumer Staples Stocks, Explained
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Best Energy Stocks – Energy Stocks to Buy Now
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.